Search

Your search keyword '"DeJesus, Edwin"' showing total 737 results

Search Constraints

Start Over You searched for: Author "DeJesus, Edwin" Remove constraint Author: "DeJesus, Edwin"
737 results on '"DeJesus, Edwin"'

Search Results

103. 1002. A Daily Single Tablet Regimen (STR) of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in Virologically-Suppressed Adults Living with HIV and End Stage Renal Disease on Chronic Hemodialysis

106. Fostemsavir in Adults with Multidrug-Resistant HIV-1 Infection

107. The Major Genetic Determinants of HIV-1 Control Affect HLA Class I Peptide Presentation

117. Maraviroc for Previously Treated Patients with R5 HIV-1 Infection

126. Concomitant Use of an Active Boosted Protease Inhibitor with Enfuvirtide in Treatment-Experienced, HIV-Infected Individuals: Recent Data and Consensus Recommendations

132. Tenofovir, Equivalence, and Noninferiority

136. Valacyclovir for the suppression of recurrent genital herpes in human immunodeficiency virus--infected subjects

138. MOESM1 of Darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-experienced, virologically suppressed patients with HIV-1: subgroup analyses of the phase 3 EMERALD study

139. Supplemental material for Pharmacokinetic interaction of riociguat and antiretroviral combination regimens in HIV-1-infected adults

140. Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 96-week results of a randomised, double-blind, non-inferiority, phase 3 trial

141. A Phase IIa Study Evaluating Safety, Pharmacokinetics, and Antiviral Activity of GSK2838232, a Novel, Second-generation Maturation Inhibitor, in Participants With Human Immunodeficiency Virus Type 1 Infection

142. Fc Gamma Receptor Polymorphisms Modulated the Vaccine Effect on HIV-1 Risk in the HVTN 505 HIV Vaccine Trial

144. 318. Tenofovir Alafenamide (TAF) vs. Tenofovir Disoproxil Fumarate (TDF) in Hispanic/Latinx and Black Participants: Efficacy, Bone and Renal Safety Results from a Pooled Analysis of 7 Clinical Trials

147. 2840. Long-term Efficacy, Safety, and Durability of CAB and RPV as Two Drug Oral Maintenance Therapy: LATTE Week 312 Results

150. A randomized, controlled trial of initial anti-retroviral therapy with abacavir/lamivudine/zidovudine twice-daily compared to atazanavir once-daily with lamivudine/zidovudine twice-daily in HIV-infected patients over 48 weeks (ESS100327, the ACTION Study)

Catalog

Books, media, physical & digital resources